StonvexLoading…
StonvexStonvexStonvexCore line items from RBKB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.98M | $3.00M | $2.88M | $2.83M |
Operating Income | $12.69M | $-10.94M | $5.61M | $8.90M |
Net Income | $10.04M | $-8.62M | $4.39M | $7.00M |
EPS (Diluted) | $0.92 | $-0.80 | $0.40 | $0.64 |
Total Assets | $1.30B | $1.26B | $1.31B | $1.34B |
Total Liabilities | $1.16B | $1.13B | $1.20B | $1.23B |
Cash & Equivalents | $101.99M | $37.48M | $22.13M | $31.38M |
Free Cash Flow OCF − CapEx | $10.89M | $7.68M | $6.47M | $13.66M |
Shares Outstanding | 11.14M | 11.09M | 11.07M | 11.28M |